Rsp5 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Rsp5 protein, an essential HECT-type E3 ubiquitin ligase. Rsp5, primarily found in Saccharomyces cerevisiae (yeast), plays a pivotal role in the ubiquitin-proteasome system (UPS), a process critical for regulating protein turnover and maintaining cellular homeostasis. As an E3 ligase, Rsp5 is responsible for recognizing substrates and facilitating their ubiquitination, which tags them for degradation or modifies their function. Rsp5 is unique in that it ubiquitinates a wide variety of substrates, including those involved in protein quality control, membrane trafficking, and stress response mechanisms. Inhibitors of Rsp5 interfere with this ubiquitination process, thereby modulating the cellular pathways associated with protein degradation, signaling, and trafficking. These compounds can be of interest in fundamental biochemical studies because they allow researchers to probe how ubiquitin ligases like Rsp5 regulate key cellular processes.
Chemically, Rsp5 inhibitors are often designed to bind directly to the catalytic HECT domain of the enzyme, thereby blocking its ability to transfer ubiquitin from the E2 conjugating enzyme to its substrates. Inhibiting Rsp5 can disrupt multiple cellular pathways, such as endocytosis and autophagy, given its regulatory role in membrane protein turnover and response to nutrient deprivation. In some cases, inhibitors might act allosterically by modifying the conformation of Rsp5, indirectly preventing its interaction with target substrates. The specificity of these inhibitors is critical, as Rsp5 shares structural homology with other E3 ubiquitin ligases, particularly in the conserved HECT domain. Therefore, the design of inhibitors often requires a deep understanding of both the structural features of Rsp5 and its interaction surfaces with other proteins. By studying Rsp5 inhibition, researchers can gain deeper insights into the broader mechanisms of cellular regulation governed by the ubiquitin system, and understand how proteostasis is maintained under various physiological and environmental conditions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
Hydrogen peroxide (H2O2) can act as an indirect inhibitor of Rsp5. It modifies the cysteine residues in Rsp5, impacting its ubiquitin ligase activity. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 is a ubiquitin-activating enzyme inhibitor that indirectly affects Rsp5 by inhibiting the upstream ubiquitination process. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Clasto-lactacystin β-lactone, by inhibiting proteasomal degradation, indirectly affects Rsp5's function in protein ubiquitination. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
MLN4924, a NEDD8-activating enzyme inhibitor, indirectly affects Rsp5 by disrupting the neddylation pathway, which is essential for Rsp5 function. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
IU1, an inhibitor of deubiquitinating enzyme USP14, indirectly impacts Rsp5 function by altering proteasome-associated deubiquitinating activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, indirectly affects Rsp5 by inhibiting the degradation of ubiquitinated proteins, a downstream effect of Rsp5 activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132, a peptide aldehyde that inhibits proteasomes, indirectly influences Rsp5 activity by preventing the degradation of ubiquitinated proteins. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, indirectly affects Rsp5 by modulating signaling pathways that are downstream of Rsp5-mediated ubiquitination. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide, known for its immunomodulatory effects, can indirectly affect Rsp5 through its influence on the ubiquitin-proteasome system. | ||||||